• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在ⅢA型黏多糖贮积症(Sanfilippo A)患者中鉴定出16种硫酸酰胺酶基因突变,包括常见的R74C突变。

Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A).

作者信息

Bunge S, Ince H, Steglich C, Kleijer W J, Beck M, Zaremba J, van Diggelen O P, Weber B, Hopwood J J, Gal A

机构信息

Institut für Humangenetik, Universitäts-Krankenhaus Eppendorf, Hamburg, Germany.

出版信息

Hum Mutat. 1997;10(6):479-85. doi: 10.1002/(SICI)1098-1004(1997)10:6<479::AID-HUMU10>3.0.CO;2-X.

DOI:10.1002/(SICI)1098-1004(1997)10:6<479::AID-HUMU10>3.0.CO;2-X
PMID:9401012
Abstract

Mucopolysaccharidosis type IIIA (MPS IIIA or Sanfilippo A disease) is a storage disorder caused by deficiency of the lysosomal enzyme sulfamidase. Mutation screening, using SSCP/heteroduplex analyses on cDNA and genomic DNA fragments, was performed in a group of 42 European patients. Sixteen of the 17 different gene mutations characterized have not been previously described. The spectrum of gene lesions consists of two 1-bp deletions (1091delC, 1093delG), an 18-bp duplication (421ins18), a splice site mutation (IVS2-2A-->G), and 13 different missense point mutations. As in other lysosomal storage disorders, the phenotypic heterogeneity is associated with a considerable genetic heterogeneity. The missense mutation R74C, which alters an evolutionary conserved amino acid in the active site of the enzyme, was found on 56% of alleles of 16 Polish patients, whereas it was less frequent among German patients (21% of disease alleles). R245H, a previously reported common mutation, represents 35% of disease alleles in German patients, but only 3% in Polish patients. As the combined frequency of the common mutations (R74C and R245H) in German and Polish populations exceeds 55%, screening for these two mutations will assist molecular genetic diagnosis of MPS IIIA and allow heterozygote testing in these populations.

摘要

ⅢA型黏多糖贮积症(MPS IIIA或Sanfilippo A病)是一种由溶酶体酶硫酸酰胺酶缺乏引起的贮积病。对42名欧洲患者进行了突变筛查,采用单链构象多态性/异源双链分析对cDNA和基因组DNA片段进行检测。所鉴定的17种不同基因突变中有16种此前未曾描述过。基因损伤谱包括两个1bp的缺失(1091delC、1093delG)、一个18bp的重复(421ins18)、一个剪接位点突变(IVS2-2A→G)以及13种不同的错义点突变。与其他溶酶体贮积病一样,表型异质性与相当大的遗传异质性相关。错义突变R74C改变了该酶活性位点一个进化保守的氨基酸,在16名波兰患者56%的等位基因中发现,而在德国患者中频率较低(占疾病等位基因的21%)。R245H是此前报道的常见突变,在德国患者的疾病等位基因中占35%,而在波兰患者中仅占3%。由于德国和波兰人群中常见突变(R74C和R245H)的合并频率超过55%,对这两种突变进行筛查将有助于MPS IIIA的分子遗传学诊断,并可在这些人群中进行杂合子检测。

相似文献

1
Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A).在ⅢA型黏多糖贮积症(Sanfilippo A)患者中鉴定出16种硫酸酰胺酶基因突变,包括常见的R74C突变。
Hum Mutat. 1997;10(6):479-85. doi: 10.1002/(SICI)1098-1004(1997)10:6<479::AID-HUMU10>3.0.CO;2-X.
2
Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.土耳其的桑菲利波综合征:A 型和 B 型亚型中新突变的鉴定。
Hum Mutat. 2002 Feb;19(2):184-5. doi: 10.1002/humu.9009.
3
Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.ⅢA型和ⅢB型黏多糖贮积症的分子遗传学:诊断、临床及生物学意义
Hum Mutat. 2001 Oct;18(4):264-81. doi: 10.1002/humu.1189.
4
Mutation 1091delC is highly prevalent in Spanish Sanfilippo syndrome type A patients.1091delC突变在西班牙A型桑菲利波综合征患者中高度流行。
Hum Mutat. 1998;12(4):274-9. doi: 10.1002/(SICI)1098-1004(1998)12:4<274::AID-HUMU9>3.0.CO;2-F.
5
Mucopolysaccharidosis type IIIB (Sanfilippo B): identification of 18 novel alpha-N-acetylglucosaminidase gene mutations.IIIB型粘多糖贮积症(Sanfilippo B型):18种新型α-N-乙酰氨基葡萄糖苷酶基因突变的鉴定
J Med Genet. 1999 Jan;36(1):28-31.
6
Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome.硫酸酰胺酶基因的克隆及Sanfilippo A综合征突变的鉴定。
Nat Genet. 1995 Dec;11(4):465-7. doi: 10.1038/ng1295-465.
7
Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.通过对ⅢA型黏多糖贮积症患者培养成纤维细胞中乙酰肝素-N-硫酸酯酶进行免疫定量分析预测Sanfilippo综合征的表型严重程度
Mol Genet Metab. 2001 Aug;73(4):306-12. doi: 10.1006/mgme.2001.3190.
8
Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes.桑菲利波B型综合征(粘多糖贮积症IIIB型):等位基因异质性与广泛的临床表型相对应。
Eur J Hum Genet. 1999 Jan;7(1):34-44. doi: 10.1038/sj.ejhg.5200242.
9
Expression and functional characterization of human mutant sulfamidase in insect cells.人突变型硫酸酯酶在昆虫细胞中的表达及功能特性
Mol Genet Metab. 2004 Nov;83(3):246-51. doi: 10.1016/j.ymgme.2004.07.001.
10
Novel mutations in Sanfilippo A syndrome: implications for enzyme function.桑菲力波综合征A型的新型突变:对酶功能的影响
Hum Mol Genet. 1997 Sep;6(9):1573-9. doi: 10.1093/hmg/6.9.1573.

引用本文的文献

1
VarMeter2: An enhanced structure-based method for predicting pathogenic missense variants through Mahalanobis distance.VarMeter2:一种基于结构的增强型方法,通过马氏距离预测致病性错义变异。
Comput Struct Biotechnol J. 2025 Mar 1;27:1034-1047. doi: 10.1016/j.csbj.2025.02.008. eCollection 2025.
2
Lysosomal Dysfunction: Connecting the Dots in the Landscape of Human Diseases.溶酶体功能障碍:梳理人类疾病图谱中的关联
Biology (Basel). 2024 Jan 7;13(1):34. doi: 10.3390/biology13010034.
3
Identification of genetic variants associated with a wide spectrum of phenotypes clinically diagnosed as Sanfilippo and Morquio syndromes using whole genome sequencing.
利用全基因组测序鉴定与临床诊断为Sanfilippo综合征和Morquio综合征的广泛表型相关的基因变异。
Front Genet. 2023 Sep 11;14:1254909. doi: 10.3389/fgene.2023.1254909. eCollection 2023.
4
Natural History and Molecular Characteristics of Korean Patients with Mucopolysaccharidosis Type III.韩国黏多糖贮积症III型患者的自然病史及分子特征
J Pers Med. 2022 Apr 21;12(5):665. doi: 10.3390/jpm12050665.
5
Mucopolysaccharidosis III: Molecular basis and treatment.黏多糖贮积症 III 型:分子基础与治疗。
Pediatr Endocrinol Diabetes Metab. 2021;27(3):201-208. doi: 10.5114/pedm.2021.109270.
6
Hip pathologies in mucopolysaccharidosis type III.黏多糖贮积症 III 型的髋关节病变。
J Orthop Surg Res. 2021 Mar 19;16(1):201. doi: 10.1186/s13018-021-02340-6.
7
Epidemiology of Mucopolysaccharidoses Update.黏多糖贮积症流行病学最新进展
Diagnostics (Basel). 2021 Feb 10;11(2):273. doi: 10.3390/diagnostics11020273.
8
Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group.ⅢA型黏多糖贮积症的造血干细胞移植:病例描述及与基因型匹配对照组的比较
Mol Genet Metab Rep. 2020 Mar 23;23:100578. doi: 10.1016/j.ymgmr.2020.100578. eCollection 2020 Jun.
9
The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype.黏多糖贮积症 III 型表型谱的衰减端:从迟发性稳定认知障碍到非神经病变表型。
Orphanet J Rare Dis. 2019 Nov 12;14(1):249. doi: 10.1186/s13023-019-1232-0.
10
Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study.患者的分子诊断:一项多中心研究。
Eur J Pediatr. 2019 May;178(5):739-753. doi: 10.1007/s00431-019-03341-8. Epub 2019 Feb 26.